Description

CTTHWGFTLC, CYCLIC TFA is a cyclic peptide inhibitor for matrix metalloproteinases MMP-2 and MMP-9. The IC50 value for MMP-9 is ~8 μM[1].–80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture and light, under nitrogen)–COVID-19-immunoregulation–C54H72F3N13O16S2—-[1]Medina OP, et al. Binding of novel peptide inhibitors of type IV collagenases to phospholipid membranes and use in liposome targeting to tumor cells in vitro. Cancer Res. 2001 May 15;61(10):3978-85.—-1280.35–98.60–O=C(N[C@H]1CC2=CNC3=CC=CC=C23)[C@H](CC4=CN=CN4)NC([C@]([H])([C@@H](C)O)NC([C@]([H])([C@@H](C)O)NC([C@@H](N)CSSC[C@@H](C(O)=O)NC([C@H](CC(C)C)NC([C@]([H])([C@@H](C)O)NC([C@H](CC5=CC=CC=C5)NC(CNC1=O)=O)=O)=O)=O)=O)=O)=O.O=C(C(F)(F)F)O–Cancer; Inflammation/Immunology–DMSO : ≥ 50 mg/mL–MMP–MMP-2;MMP-9–Metabolic Enzyme/Protease–Peptides